These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22451238)

  • 1. Evidence-based medicine and the selection of lipid-lowering therapy in type 2 diabetes.
    Aguilar-Salinas CA; Mehta R; Gomez-Diaz RA
    Curr Diab Rep; 2012 Jun; 12(3):221-3. PubMed ID: 22451238
    [No Abstract]   [Full Text] [Related]  

  • 2. PCSK9 inhibitors- A new age in lipid management?
    Grant PJ
    Diab Vasc Dis Res; 2017 May; 14(3):171. PubMed ID: 28467196
    [No Abstract]   [Full Text] [Related]  

  • 3. Current knowledge and future directions on cardiovascular disease in diabetes.
    Maahs DM; Snell-Bergeon JK
    Diabetes Technol Ther; 2012 Jun; 14 Suppl 1(Suppl 1):S75-6. PubMed ID: 22650228
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lipids: diagnosis and therapy in type 2 diabetes].
    Wascher TC; Paulweber B; Toplak H; Saely C; Drexel H
    Wien Klin Wochenschr; 2012 Dec; 124 Suppl 2():28-30. PubMed ID: 23250461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent blood pressure, glycemic and lipid control for the prevention of vascular complications of type II diabetes mellitus: a long overdue objective?
    Athyros VG; Mitsiou EK; Tziomalos K; Karagiannis A; Mikhailidis DP
    Curr Vasc Pharmacol; 2010 Jan; 8(1):1-4. PubMed ID: 20394107
    [No Abstract]   [Full Text] [Related]  

  • 6. Should you put all diabetic patients on statins?
    Leiter LA
    J Fam Pract; 2007 Apr; 56(4):294-300. PubMed ID: 17403328
    [No Abstract]   [Full Text] [Related]  

  • 7. A case for lipid-lowering?
    Durrington P
    Diabet Med; 2000 Sep; 17 Suppl 2():4-5. PubMed ID: 11048824
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of lipids and type 2 diabetes.
    Hermayer KL
    Curr Cardiol Rep; 2004 Nov; 6(6):443-50. PubMed ID: 15485606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ways to reduce cardiovascular disease in diabetes.
    Garg SK; DiDomenico D; Switzer S
    Diabetes Technol Ther; 2012 Jun; 14 Suppl 1():S1-2. PubMed ID: 22650219
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperlipidemia and fibrates with special reference to diabetes].
    Henkel E; Hanefeld M
    Herz; 2001 Dec; 26(8):523-30. PubMed ID: 11820155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk.
    Duntas L; Kolovou G
    Future Cardiol; 2011 Mar; 7(2):137-44. PubMed ID: 21453018
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians.
    Vijan S; Hayward RA;
    Ann Intern Med; 2004 Apr; 140(8):650-8. PubMed ID: 15096337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential implications of the choice among three alternative treatment targets for apolipoprotein B100 in the management of patients with type 2 diabetes and chronic kidney disease.
    Boronat M; García-Cantón C; López-Ríos L; Quevedo V; Lorenzo DL; Batista F; Riaño M; Nóvoa FJ
    Diab Vasc Dis Res; 2014 Jan; 11(1):53-9. PubMed ID: 24254975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incretins and pancreatitis--what happens next? A personal viewpoint.
    Robson J
    Diabet Med; 2013 Oct; 30(10):1156-9. PubMed ID: 24073726
    [No Abstract]   [Full Text] [Related]  

  • 15. Summaries for patients. Control of lipids in patients with type 2 diabetes: recommendations from the American College of Physicians.
    Ann Intern Med; 2004 Apr; 140(8):I85. PubMed ID: 15096362
    [No Abstract]   [Full Text] [Related]  

  • 16. Following the LEADER - why this and other recent trials signal a major paradigm shift in the management of type 2 diabetes.
    Kosiborod M
    J Diabetes Complications; 2017 Feb; 31(2):517-519. PubMed ID: 27839923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials.
    Armitage J; Collins R
    Heart; 2000 Oct; 84(4):357-60. PubMed ID: 10995396
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of combination therapy in type 2 diabetes in the post-ACCORD era.
    Kuritzky L
    Curr Diab Rep; 2012 Jun; 12(3):227-9. PubMed ID: 22528598
    [No Abstract]   [Full Text] [Related]  

  • 19. The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization. The DAIS Project Group.
    Steiner G
    Diabetologia; 1996 Dec; 39(12):1655-61. PubMed ID: 9081851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case for lipid lowering? Response to Dr Paul Durrington.
    Yudkin JS
    Diabet Med; 2001 May; Suppl 3():11-2. PubMed ID: 11534306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.